Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
232,945,000
-
Total 13F shares
-
184,499,674
-
Share change
-
+4,894,784
-
Total reported value
-
$571,910,625
-
Put/Call ratio
-
33%
-
Price per share
-
$3.10
-
Number of holders
-
192
-
Value change
-
+$17,365,138
-
Number of buys
-
113
-
Number of sells
-
62
Institutional Holders of Gossamer Bio, Inc. - Common Stock, $0.0001 par value (GOSS) as of Q4 2025
As of 31 Dec 2025,
Gossamer Bio, Inc. - Common Stock, $0.0001 par value (GOSS) was held by
192 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
184,499,674 shares.
The largest 10 holders included
NEA Management Company, LLC, BlackRock, Inc., Octagon Capital Advisors LP, VANGUARD GROUP INC, STATE STREET CORP, ARCH Venture Management, LLC, SAMSARA BIOCAPITAL, LLC, Siren, L.L.C., 683 Capital Management, LLC, and HHLR ADVISORS, LTD..
This page lists
193
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.